Navigation Links
Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products' Neurodegenerative Diagnostics
Date:12/2/2008

OMAHA, Neb. and HOUSTON, Dec. 2 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) and Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM) today announced that Transgenomic has signed a letter of intent to acquire exclusive rights for Power3 Medical's Neurodegenerative Biomarkers, which include NuroPro(R), a proposed diagnostic for Alzheimer's and Parkinson's disease. Transgenomic plans to offer NuroPro(R) in its CLIA-certified molecular diagnostics laboratory as well as support the tests with development resources.

Power3's technology assigns a probability score that reflects how closely a patient's sample fits a biostatistical model for a neurological disease (NuroPro(R)), and indicates if the patient should be recommended for further follow-up by the clinician. These technologies would join Transgenomic's robust portfolio of molecular diagnostics including tests for mitochondrial disorders, oncology and hematology, molecular pathology and inherited diseases.

Craig Tuttle, CEO of Transgenomic, said, "Physicians face a common challenge when treating patients with these devastating diseases -- how to diagnose them earlier and more accurately so their patients can receive treatment sooner and receive greater benefit from treatment. In this respect, the proteomic tests for detection of early disease developed by Power3 are very attractive; particularly when combined with our company's demonstrated strength in robust and sensitive genomics tests for detection of increased disease susceptibility. Moreover, as we are already calling on neurologists with our current lab sales organization, these new assays will add significant depth to our neurological sales portfolio."

Dr. Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc., said, "It is critical to have the ability to diagnose Alzheimer's disease more accurately, earlier, and faster than c
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Transgenomic Awarded SBIR Grant to Support Development of SURVEYOR(R) Endonuclease Adaptor-ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation
2. Transgenomic to Present at Rodman & Renshaw 10th Annual Healthcare Conference
3. Transgenomic, Inc. Reports Third Quarter 2008 Results
4. Webcast Alert: Transgenomic Inc. Announces Third Quarter 2008 Earnings Release Conference Call Webcast
5. Transgenomic Announces Partnership With Key Genomics for Ovarian Cancer Assay to Guide Therapeutic Options
6. Transgenomic Reports Second Quarter 2008 Results
7. Reminder: Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
8. Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
9. Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation
10. Webcast Alert: Transgenomic Inc. Announces First Quarter 2008 Earnings Release Conference Call Webcast
11. Transgenomic Opens Pharmacogenomics Laboratory in China

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...NEWYORK,Nov.25/PRNewswire/--Reportlinker.comannoun...alogue: ,, BrazilBioethanolMarketAnalysisandFo...p0165503/Brazil-Bioethanol-Market-Analysis-and-For...nalysisandForecaststo2013 ,, Summary ,, Th...obalbioethanolmarketandtheBrazilbioethanolmarketin...
(Date:11/24/2009)...release is available in German . , Whether ...rds: RFID tags (Radio Frequency Identification) ar...e. They make it possible to label objects or goods...y. The appropriate scanner can read and process th... affixed to goods under production conditions of u...
(Date:11/24/2009)... Ambassador to also Visit Detroit...009 -- , , ,Who: David Appia, French Ambassador fo...f the Invest in France Agency, , , , ,What: Ambas...cuss recent pro-business initiatives adopted by Fr...academic landscape for innovation and development....
(Date:11/24/2009)...SANTACRUZ,Calif.,Nov.24/PRNewswire/--Twomorepresti...on,sleadingonlinejobboardandcareerssiteforlifescie...versityarenowmembersofthejobboard,joining28otherma...ard, www.biocareercenter.com ,isonlyforpost-gradua...iencecareersitesontheInternet,BioCareerCenteristhe...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2
... BOSTON, Jan. 15 PAREXEL International Corporatio...tical services organization, announced today it ha...ident and Chief Information Officer (CIO). Ms. Hop...mation technology (IT) initiatives and integrating... global basis. , , Prior to joining PAREXEL, Ms. ...
... ST. LOUIS, Jan. 14 As the latest step in its..., Monsanto Company,(NYSE: MON ) today announced ...increase in the quarterly dividend on its common s...are. The dividend is payable on April 24, 2009 to,...we have often said, when farmers succeed we succee...
... LAVAL, QC, Jan. 14 /PRNewswire-FirstCall/ - BioSy...veloping biotherapeutic thermogels for regenerativ...enrolment next month for the Canadian-European piv...Gel(R). To date, the Company has enrolled more tha...l be permitted to enrol additional subjects until ...
Other Biology Technology:PAREXEL Appoints Josephine Hoppe to Chief Information Officer 2PAREXEL Appoints Josephine Hoppe to Chief Information Officer 3PAREXEL Appoints Josephine Hoppe to Chief Information Officer 4Monsanto Board Approves 10 Percent Dividend Increase 2BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009 2BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009 3BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009 4
(Date:11/25/2009)... may be used to boost resistance to, or slow, the ... Medicine researchers report in a study published .... , Parkinson,s disease is caused by a degenerat... known as the substantia nigra, which is responsib... dopamine in late-stage Parkinson,s causes symptom...
(Date:11/25/2009)... Research Laboratory in the University of Haifa,s ...gious Johnson & Johnson Focused Funding grant for ...age in Parkinson,s disease. The award, which is gr...tion and excellence in science, was announced in 2...t an event at the Hyatt Regency Hotel in New Jerse...
(Date:11/25/2009)...ors recently received funding from the National Sc...cial to understanding the environment. The three g...ssistant professor in the Department of Biological...ate research projects. , His first project, titl...unctions from the Leaf to the Landscape," will exa...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Kent State University professors focus research on the environment with grants totaling $890,000 2New Nominee for WHO Regional Director for Europe 57339 1New Nominee for WHO Regional Director for Europe 57339 2Video 3A NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer 57336 1Video 3A NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer 57336 2Video 3A NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer 57336 3Video 3A NFL Season Kicks Off With Campaign to Know Your Stats About Prostate Cancer 57336 4GenVec Receives NASDAQ Notice of Minimum Bid Price Non Compliance 57333 1GenVec Receives NASDAQ Notice of Minimum Bid Price Non Compliance 57333 2GenVec Receives NASDAQ Notice of Minimum Bid Price Non Compliance 57333 3
...sts have demonstrated a new way to assess the pote...--a technique that could also be used to monitor a...isticated, noninvasive medical imaging tools. Scie...en National Laboratory, whose findings are reporte...Medicine,s Journal of Nuclear Medicine, used posit...
...s newest polymer innovation, the first DuPont poly...ognized by the China State Intellectual Property O... Visionary Innovation" at a recent award ceremony....ive the 2005 "New Technologies in Renewable Materi...d Environmental Conference, sponsored by the Socie...
...e sclerosis (MS) can be an unpredictable disease. ...healthy nerve cells and disrupts normal nerve sign...s—including tingling, paralysis, pain, fatigue, an...in combination, sporadically or persistently. Alth...-ups are common in the majority of patients. , MS...
Other Biology News:PET/MRI scans may help unravel mechanisms of prenatal drug damage 2PET/MRI scans may help unravel mechanisms of prenatal drug damage 3PET/MRI scans may help unravel mechanisms of prenatal drug damage 4DuPont's first biologically derived polymer receives global recognition 2Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients 2
...micron range are part of your production or produc...particle size is important to you. You need an ana...ations in your sample every time. The N5 Submicron...ectroscopy (PCS) , which determines particle size ...
MiniMACS Separation Unit from Miltenyi Biotec
...body Binding: High, 400 ng IgG/cm 2 (1cm2 = 100 &.../Ionic , Performance Certified: Well-to-Well, CV =...me: 360 µl , Packaging: 5 plates per sealed ...ene formulation , High antibody binding surface im...
SILVER SEQUENCE Staining Reagents from Promega
Biology Products: